Sucampo Pharmaceuticals Inc., of Rockville, Md., said it closed a $250 million credit facility in connection with the financing of its acquisition of Japanese firm R-Tech Ueno Ltd. Sucampo has funded all shares and stock acquisition rights tendered during the previously announced tender offer and has also closed its share purchase agreement with R-Tech Ueno’s founders and a related entity.